Epidemiological studies have implicated dothiepin in a greater number
of self-poisoning deaths than would be expected from its use. We have
prospectively assessed the clinical toxicity of dothiepin and other tr
icyclic antidepressants (TCAs) in overdose. We followed-up consecutive
ly admitted patients with TCA poisoning managed by our department betw
een January, 1987, and August, 1992. 75 patients had taken dothiepin,
101 amitriptyline, 83 doxepin, and 61 other TCAs. Death after TCA pois
oning is rare nowadays, so we used intermediate outcome measures-gener
al seizures, tachyarrhythmias, sedation, and QRS width on the electroc
ardiogram. 15 patients had seizures and 7 tachyarrhythmias. When we ex
cluded patients who had taken more than one TCA, general seizures were
more likely after dothiepin than after other TCAs (9/67 vs 5/220) as
were arrhythmias (4/67 vs 3/220). Rates of other complications were si
milar. The dothiepin group had ingested a larger dose, attributable to
the larger average tablet strength, than patients who took other TCAs
. The odds ratio for seizures with dothiepin versus other TCAs was 6.7
(95% Cl 2.2-20.7) unadjusted and 7.1 (2.2-23.2) after adjustment for
sex, age, and ingested dose. The corresponding odds ratios for arrhyth
mias were 4.6 (1.0-21.1) and 3.4 (0.7-16.3). Dothiepin in overdose see
ms to be proconvulsant. Patients with only minor sedation and normal l
imb-lead QRS width may still have major complications. Consideration s
hould be given to the use of other antidepressants in patients at risk
of seizures or suicide. Regulatory authorities should review the need
for a 75 mg strength tablet of any TCA.